NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,096 filers reported holding NOVARTIS A G in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,543,077 | -3.6% | 15,149 | -4.5% | 0.07% | +1.5% |
| Q2 2023 | $1,600,331 | +9.2% | 15,859 | -0.4% | 0.07% | +4.8% |
| Q1 2023 | $1,465,468 | -13.4% | 15,929 | -14.6% | 0.06% | -17.1% |
| Q4 2022 | $1,692,109 | +15.6% | 18,652 | -3.1% | 0.08% | +8.6% |
| Q3 2022 | $1,464,000 | -13.0% | 19,257 | -3.3% | 0.07% | -5.4% |
| Q2 2022 | $1,683,000 | -9.4% | 19,915 | -5.9% | 0.07% | +1.4% |
| Q1 2022 | $1,857,000 | -6.1% | 21,164 | -6.3% | 0.07% | -2.7% |
| Q4 2021 | $1,977,000 | -0.6% | 22,599 | -7.1% | 0.08% | -10.7% |
| Q3 2021 | $1,989,000 | -18.9% | 24,327 | -9.5% | 0.08% | -16.0% |
| Q2 2021 | $2,452,000 | -12.6% | 26,874 | -18.2% | 0.10% | -16.0% |
| Q1 2021 | $2,807,000 | -35.6% | 32,839 | -28.8% | 0.12% | -39.0% |
| Q4 2020 | $4,356,000 | -65.8% | 46,134 | -68.5% | 0.20% | -68.3% |
| Q3 2020 | $12,726,000 | +0.4% | 146,341 | +0.8% | 0.62% | -12.0% |
| Q2 2020 | $12,678,000 | +10.1% | 145,161 | +3.9% | 0.70% | -3.0% |
| Q1 2020 | $11,515,000 | -11.4% | 139,666 | +1.8% | 0.72% | +11.1% |
| Q4 2019 | $12,992,000 | +13.2% | 137,206 | +3.9% | 0.65% | +6.6% |
| Q3 2019 | $11,473,000 | -3.5% | 132,028 | +1.4% | 0.61% | -7.7% |
| Q2 2019 | $11,893,000 | +1.6% | 130,248 | +7.0% | 0.66% | -2.8% |
| Q1 2019 | $11,703,000 | +13.6% | 121,728 | +1.4% | 0.68% | -2.6% |
| Q4 2018 | $10,299,000 | +3.4% | 120,022 | +3.8% | 0.70% | +15.2% |
| Q3 2018 | $9,960,000 | +240.9% | 115,598 | +263.7% | 0.61% | +53.8% |
| Q3 2015 | $2,922,000 | -10.2% | 31,787 | -4.0% | 0.39% | -7.3% |
| Q2 2015 | $3,255,000 | -1.7% | 33,105 | -1.4% | 0.42% | -5.8% |
| Q1 2015 | $3,311,000 | +23.8% | 33,583 | +16.4% | 0.45% | +14.8% |
| Q4 2014 | $2,674,000 | +5.2% | 28,860 | +6.8% | 0.39% | -3.4% |
| Q3 2014 | $2,543,000 | +7.1% | 27,016 | +3.0% | 0.41% | +1.8% |
| Q2 2014 | $2,374,000 | +13.9% | 26,226 | +6.9% | 0.40% | +2.6% |
| Q1 2014 | $2,085,000 | +21.8% | 24,525 | +15.1% | 0.39% | +10.2% |
| Q4 2013 | $1,712,000 | +42.4% | 21,307 | +36.0% | 0.35% | +18.8% |
| Q3 2013 | $1,202,000 | +31.9% | 15,670 | +21.5% | 0.30% | +8.8% |
| Q2 2013 | $911,000 | – | 12,892 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |